Share

Mexico participates in Walvax COVID-19 vaccine trials

Media Dec 7, 2021 adn40

Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.

Related Links

Walvax Publishes Immunogenicity and Safety Data from Phase 3 Clinical Study of PCV13 (the 2nd available 13-valent pneumococcal polysaccharide conjugate vaccine worldwide) in Frontiers in Microbiology

CEPI, Shanghai Zerun Biotech and Walvax Biotech expand collaboration to develop COVID-19 multi-variant vaccine

Walvax’s PCV13-TT Receives Endorsement from the Pediatric Infectious Disease Society of Thailand